Device Trial Radar · NCT07494838
IMAGES: Identifying Metabolic Imaging Association With Genicular Artery Embolization Success
Last checked: Nov 19, 2026Latest source record: Nov 18, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
25
Planned (sponsor's estimate)
Start
Dec 30, 2026
Primary completion
Jun 30, 2027
Study completion Jun 30, 2027
Sponsor
- Lead sponsor
- Lucas R. Cusumano, MDAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Mar 27, 2026
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Diagnostic
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 40 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Several clinical trials on genicular artery embolization (GAE) show significant clinical benefit for the majority of patients. However, a proportion of patients do not benefit from GAE, and responses vary across individual patients. Changes in metabolic activity on non-invasive imaging may correlate with improvement in symptoms of knee osteoarthritis. This study will assess changes in metabolic uptake on a hybrid positron emission tomography/magnetic resonance imaging (PET/MRI) system in subjects undergoing GAE.
Conditions
- Knee Osteoarthritis
- Knee Discomfort
- Knee Pain Chronic
- Knee Swelling Pain
Interventions
EmbolizationDevice
Genicular artery embolization
Primary outcomes
What the sponsor says the trial is designed to measure.
- Compare metabolic activityTime frame: Screening, Month 6
Locations
1 site in 1 country. Site status is shown where the registry gives one.
University of California, Los Angeles
Los Angeles, California · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.